Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes

T M Fu, J B Ulmer, M J Caulfield, R R Deck, A Friedman, S Wang, X Liu, J J Donnelly, M A Liu, T M Fu, J B Ulmer, M J Caulfield, R R Deck, A Friedman, S Wang, X Liu, J J Donnelly, M A Liu

Abstract

Background: MHC class I molecule-restricted cytotoxic T-lymphocyte (CTL) responses are induced following either intramuscular (i.m.) injection of a DNA plasmid encoding influenza virus nucleoprotein (NP) or transplantation of myoblasts stably transfected with the NP gene, the latter indicating that synthesis of NP by myocytes in vivo is sufficient to induce CTL. The present study was designed to investigate the role of muscle cells and involvement of professional antigen-presenting cells (APCs) in priming CTL responses following DNA vaccination.

Materials and methods: Parent-->F1 bone marrow (BM) chimeric mice were generated whose somatic cells include muscle cells bearing both parental MHC haplotypes, while their professional APCs express only the donor MHC haplotypes.

Results and conclusions: Upon injection of NP DNA, or after infection with influenza virus, CTL responses generated in the chimeras were restricted to the donor MHC haplotype. Thus cells of BM lineage were definitively shown to be responsible for priming such CTL responses after infection or DNA immunization. Moreover, expression of antigen by muscle cells in BM chimeric mice after myoblast transplantation is sufficient to induce CTL restricted only by the MHC haplotype of the donor BM. This indicates that transfer of antigen from myocytes to professional APCs can occur, thus obviating a requirement for direct transfection of BM-derived cells.

References

    1. Science. 1990 Mar 23;247(4949 Pt 1):1465-8
    1. J Immunol. 1989 Mar 15;142(6):1847-53
    1. Science. 1991 Dec 6;254(5037):1507-9
    1. J Immunol. 1992 Jul 15;149(2):661-7
    1. Science. 1993 Mar 19;259(5102):1745-9
    1. Annu Rev Immunol. 1993;11:213-44
    1. J Virol. 1993 Jul;67(7):4062-9
    1. DNA Cell Biol. 1993 Nov;12(9):777-83
    1. Cell. 1994 Jan 28;76(2):287-99
    1. Science. 1994 May 13;264(5161):961-5
    1. Immunol Today. 1994 Jun;15(6):269-74
    1. J Immunol Methods. 1994 Dec 2;176(2):145-52
    1. J Exp Med. 1995 Sep 1;182(3):639-41
    1. J Exp Med. 1996 Mar 1;183(3):751-7
    1. Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8578-83
    1. Nat Med. 1996 Oct;2(10):1122-8
    1. J Exp Med. 1996 Oct 1;184(4):1555-60
    1. Immunology. 1996 Sep;89(1):59-67
    1. J Virol. 1997 Apr;71(4):2715-21
    1. Annu Rev Immunol. 1997;15:617-48
    1. J Immunol. 1976 Dec;117(6):2233-8
    1. Nature. 1978 Jan 19;271(5642):251-3
    1. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2844-8
    1. J Exp Med. 1978 Sep 1;148(3):766-75
    1. J Immunol. 1980 Mar;124(3):1258-62
    1. Nature. 1991 May 23;351(6324):290-6

Source: PubMed

3
구독하다